泰禾光電(603656.SH)擬競拍肥西經開區的土地使用權 作為未來擴大生產經營用地
格隆匯12月16日丨泰禾光電(603656.SH)公佈,公司擬以自有資金參與競拍位於肥西經開區的土地使用權,並授權公司管理層在董事會權限內參與競拍,並在競得土地使用權後辦理後續相關事宜,具體包括但不限於簽署相關協議及辦理土地使用權證照等。
地塊位置為肥西經開區,規劃土地用途為工業;出讓面積464.19畝;出讓年限50年;參考價為12.20萬元/畝,按此估算,此次競拍土地總參考價格為5663.118萬元。
此次競得的土地擬作為公司未來擴大生產經營用地,為公司長期穩定經營奠定基礎,有利於公司的可持續發展,符合公司戰略發展需要,不會對公司財務狀況及經營業績產生較大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.